VLA 0.00% $1.75 viralytics limited

viralytics granted chinese patent , page-4

  1. 1,656 Posts.
    lightbulb Created with Sketch. 33
    I would expected accumulation and ramping over the next 6 to 8 weeks in anticipation again of the FDA phase 2 approval. Then a possible dump on that announcement. Be careful.

    I have held VLA for over 4 years and so far have only seen continual dilution and SP pain for long term holders. Still VLA is many years away from realising its potential but CAVATAK looks promising so I continue to hold.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.